Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark McCormack

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.
Frontiers in Pharmacology|June 28, 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure MedicationsStefan Wolking, Ciarán Campbell, Caragh Stapleton, et al.
Molecular Genetics & Genomic Medicine|May 31, 2019
Influence of common SCN1A promoter variants on the severity of SCN1A-related phenotypesIris M de Lange, Wout Weuring, Ruben van 't Slot, et al.
Nature Genetics|March 25, 2014
TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural functionFernando Gómez-Herreros, Janneke H M Schuurs-Hoeijmakers, Mark McCormack, et al.
Annals of Clinical and Translational Neurology|May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsyStefan Wolking, Claudia Moreau, Mark McCormack, et al.
Epilepsia|March 17, 2022
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetamCiarán Campbell, Mark McCormack, Sonn Patel, et al.
European Journal of Human Genetics : EJHG|April 3, 2020
A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disabilityKatherine A Benson, Maire White, Nicholas M Allen, et al.
Epilepsia Open|March 15, 2019
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepineBianca Berghuis, Caragh Stapleton, Anja C M Sonsma, et al.
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlandersCynthia M Beall, Gianpiero L Cavalleri, Libin Deng, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Brain : a Journal of Neurology|May 23, 2018
Distinct HLA associations of LGI1 and CASPR2-antibody diseasesSophie Binks, James Varley, Wanseon Lee, et al.
Frontiers in Pharmacology|June 28, 2021
Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure MedicationsStefan Wolking, Ciarán Campbell, Caragh Stapleton, et al.
Molecular Genetics & Genomic Medicine|May 31, 2019
Influence of common SCN1A promoter variants on the severity of SCN1A-related phenotypesIris M de Lange, Wout Weuring, Ruben van 't Slot, et al.
Nature Genetics|March 25, 2014
TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural functionFernando Gómez-Herreros, Janneke H M Schuurs-Hoeijmakers, Mark McCormack, et al.
Annals of Clinical and Translational Neurology|May 21, 2021
Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsyStefan Wolking, Claudia Moreau, Mark McCormack, et al.
Epilepsia|March 17, 2022
A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetamCiarán Campbell, Mark McCormack, Sonn Patel, et al.
European Journal of Human Genetics : EJHG|April 3, 2020
A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disabilityKatherine A Benson, Maire White, Nicholas M Allen, et al.
Epilepsia Open|March 15, 2019
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepineBianca Berghuis, Caragh Stapleton, Anja C M Sonsma, et al.
Frontiers in Neuroscience|October 4, 2023
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrinIsabelle Boothman, Lisa M Clayton, Mark McCormack, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlandersCynthia M Beall, Gianpiero L Cavalleri, Libin Deng, et al.
Pageof 5